Table 2.
Binding Assay Results of N-Methylated Ac-Nle4-c[Asp5,d-Nal(2′)7,Lys10]-NH2 Analogues at hMCRsa
hMC1R | hMC3R | hMC4R | hMC5R | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# sequence | IC50, nM | Bind-Effic | IC50, nM | Bind-Effic | IC50, nM | Bind-Effic | IC50, nM | Bind-Effic | |||||||
1 | Nle | D | H | DNal(2′) | R | W | K | 8.7±0.9 | 100 | 3.74±0.5 | 97 | 2.4±0.2 | 98 | 6.9±1.2 | 98 |
2 | Nle | D | H | DNal(2′) | R | W | K | 12.6±1.8 | 100 | 23±4 | 97 | 18.2±2.1 | 97 | 6.1±1.1 | 98 |
3 | Nle | D | H | DNal(2′) | R | W | K | 192±20 | 77 | 20.4±3 | 77 | 16.2±2 | 70 | 16.8±2.3 | 77 |
4 | Nle | D | H | DNal(2′) | R | W | K | 1.4±0.15 | 90 | 47.4±5.2 | 95 | 6.35±1.0 | 90 | 3.41±0.6 | 96 |
5 | Nle | D | H | DNal(2′) | R | W | K | 18.7±0.30 | 80 | 27.4±2.1 | 90 | 1390±310 | 90 | 27.7±3.4 | 90 |
6 | Nle | D | H | DNal(2′) | R | W | K | 106±21 | 90 | 3.2±0.5 | 90 | 65.9±10 | 90 | 5±0.8 | 90 |
7 | Nle | D | H | DNal(2′) | R | W | K | 175±20 | 86 | 17.8±2 | 95 | 111±13 | 89 | 15±1.8 | 94 |
8 | Nle | D | H | DNal(2′) | R | W | K | 3.9±0.5 | 80 | 1.6±0.1 | 90 | 1010±1.1 | 90 | 6±1.0 | 90 |
9 | Nle | D | H | DNal(2′) | R | W | K | 3110±456 | 82 | 795±90 | 90 | 1380±110 | 101 | 95±10 | 87 |
10 | Nle | D | H | DNal(2′) | R | W | K | 196±16 | 90 | 24.9±2.1 | 99 | 134±15 | 90 | 13±0.12 | 90 |
11 | Nle | D | H | DNal(2′) | R | W | K | 111±20 | 89 | 19.7±2 | 93 | 59.4±6 | 89 | 16.46±2.1 | 93 |
12 | Nle | D | H | DNal(2′) | R | W | K | 916±120 | 92 | 412±60 | 92 | 32.2±5 | 88 | 2260±230 | 72 |
13 | Nle | D | H | DNal(2′) | R | W | K | 1050±116 | 88 | 3660±410 | 95 | 244±31 | 90 | 91±9 | 86 |
14 | Nle | D | H | DNal(2′) | R | W | K | 4.9±0.9 | 90 | 65±11 | 90 | 507±120 | 90 | 35.2±5 | 90 |
15 | Nle | D | H | DNal(2′) | R | W | K | 4.0±0.7 | 90 | 15.3±2.8 | 80 | 98±4.1 | 90 | 6.33±0.9 | 90 |
16 | Nle | D | H | DNal(2′) | R | W | K | 2520±320 | 86 | 547±70 | 80 | 1700±340 | 90 | 1670±300 | 90 |
17 | Nle | D | H | DNal(2′) | R | W | K | 246±45 | 80 | 9.7±1.2 | 90 | 203±7 | 80 | 6.66±1 | 90 |
18 | Nle | D | H | DNal(2′) | R | W | K | 246±24 | 80 | 147±23 | 90 | 549±150 | 90 | 592±70 | 80 |
19 | Nle | D | H | DNal(2′) | R | W | K | 242±32 | 74 | 106±13 | 90 | 100±8 | 79 | 268±31 | 91 |
20 | Nle | D | H | DNal(2′) | R | W | K | 256±35 | 84 | 8±11 | 86 | 722±81 | 81 | 39.7±5 | 90 |
21 | Nle | D | H | DNal(2′) | R | W | K | 16.7±2.2 | 9 | 2.5±06 | 94 | 3.96±1 | 76 | 2.82±0.8 | 90 |
22 | Nle | D | H | DNal(2′) | R | W | K | 824±1 00 | 68 | 13.7±2 | 38 | 8740±841 | 59 | 388±41 | 70 |
23 | Nle | D | H | DNal(2′) | R | W | K | 1330±200 | 70 | 2220±242 | 61 | 99.9±10 | 36 | 159±19 | 67 |
24 | Nle | D | H | DNal(2′) | R | W | K | 9.4±1.2 | 86 | 51±9 | 78 | 1070±110 | 76 | 871±91 | 84 |
25 | Nle | D | H | DNal(2′) | R | W | K | 1740±210 | 68 | 988±110 | 90 | 505±111 | 67 | 571.5±61 | 93 |
26 | Nle | D | H | DNal(2′) | R | W | K | 1070±189 | 93 | 336±42 | 82 | 787±82 | 68 | 115±13 | 92 |
27 | Nle | D | H | DNal(2′) | R | W | K | 1220±123 | 94 | 1270±210 | 92 | 188±21 | 37 | 1510±159 | 32 |
28 | Nle | D | H | DNal(2′) | R | W | K | 9.9±1.2 | 93 | 20±3 | 88 | 0.5±0.02 | 64 | 8.1±1 | 89 |
29 | Nle | D | H | DNal(2′) | R | W | K | 1460±163 | 42 | 1670±193 | 97 | 304±35 | 27 | 4290±521 | 64 |
30 | Nle | D | H | DNal(2′) | R | W | K | 1380±150 | 87 | 6050±985 | 93 | 1790±190 | 24 | 1050±120 | 24 |
31 | Nle | D | H | DNal(2′) | R | W | K | 181 0±210 | 89 | 657±76 | 94 | 949±85 | 8 | 177±21 | 75 |
32 | Nle | D | H | DNal(2′) | R | W | K | 68.4±8 | 91 | 5820±200 | 84 | 3140±270 | 19 | 257±34 | 37 |
Amino acids with N-methyl groups are highlighted in gray. IC50, concentration of peptide at 50% specific binding (N = 4). NB, 0% 125I-NDP-α- MSH displacement observed at 10 µM. Percent binding efficiency, maximal % of 125I-NDP-α-MSH displacement observed at 10 µM.